Replies to post #278318 on Anavex Life Sciences Corp (AVXL)

[imho]

Anavex will be making an MOA demonstration at CTAD. There is no other way to look at this.

The interesting question, aside from the strength of the PDD data, is what data Missling will use from AD results.

I agree. The focus will be the MOA as it relates to AD. It must be pretty compelling for CTAD to accept AVXL as LB.

So what about PDD? How much of the data will be provided? No matter what, I fully expect the company to present PDD at a Parkinson's conference. Redundant or not, I can't imagine the company not present PDD data at a Parkinson's conference. It just would not make sense.

IMHO